242 related articles for article (PubMed ID: 18660675)
1. Therapeutic targets in focal and segmental glomerulosclerosis.
Lavin PJ; Gbadegesin R; Damodaran TV; Winn MP
Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):386-92. PubMed ID: 18660675
[TBL] [Abstract][Full Text] [Related]
2. [Structure and function of the glomerular filtration barrier].
Musiał K; Zwolińska D
Pol Merkur Lekarski; 2005 Mar; 18(105):317-20. PubMed ID: 15997642
[TBL] [Abstract][Full Text] [Related]
3. The podocyte's response to injury: role in proteinuria and glomerulosclerosis.
Shankland SJ
Kidney Int; 2006 Jun; 69(12):2131-47. PubMed ID: 16688120
[TBL] [Abstract][Full Text] [Related]
4. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
[TBL] [Abstract][Full Text] [Related]
6. A Review of Podocyte Biology.
Garg P
Am J Nephrol; 2018; 47 Suppl 1():3-13. PubMed ID: 29852492
[TBL] [Abstract][Full Text] [Related]
7. Focal segmental glomerulosclerosis: recent advances.
Pollak MR
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):138-42. PubMed ID: 18277145
[TBL] [Abstract][Full Text] [Related]
8. Podocyte injury and targeting therapy: an update.
Durvasula RV; Shankland SJ
Curr Opin Nephrol Hypertens; 2006 Jan; 15(1):1-7. PubMed ID: 16340659
[TBL] [Abstract][Full Text] [Related]
9. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4.
Michaud JL; Lemieux LI; Dubé M; Vanderhyden BC; Robertson SJ; Kennedy CR
J Am Soc Nephrol; 2003 May; 14(5):1200-11. PubMed ID: 12707390
[TBL] [Abstract][Full Text] [Related]
10. Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.
Sever S; Schiffer M
Kidney Int; 2018 Jun; 93(6):1298-1307. PubMed ID: 29678354
[TBL] [Abstract][Full Text] [Related]
11. Gα12 activation in podocytes leads to cumulative changes in glomerular collagen expression, proteinuria and glomerulosclerosis.
Boucher I; Yu W; Beaudry S; Negoro H; Tran M; Pollak MR; Henderson JM; Denker BM
Lab Invest; 2012 May; 92(5):662-75. PubMed ID: 22249312
[TBL] [Abstract][Full Text] [Related]
12. The pathogenesis of focal segmental glomerulosclerosis.
Jefferson JA; Shankland SJ
Adv Chronic Kidney Dis; 2014 Sep; 21(5):408-16. PubMed ID: 25168829
[TBL] [Abstract][Full Text] [Related]
13. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
[TBL] [Abstract][Full Text] [Related]
14. Mice with mutant Inf2 show impaired podocyte and slit diaphragm integrity in response to protamine-induced kidney injury.
Subramanian B; Sun H; Yan P; Charoonratana VT; Higgs HN; Wang F; Lai KV; Valenzuela DM; Brown EJ; Schlöndorff JS; Pollak MR
Kidney Int; 2016 Aug; 90(2):363-372. PubMed ID: 27350175
[TBL] [Abstract][Full Text] [Related]
15. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
16. Detrimental effects of hypoxia on glomerular podocytes.
Singh AK; Kolligundla LP; Francis J; Pasupulati AK
J Physiol Biochem; 2021 May; 77(2):193-203. PubMed ID: 33835424
[TBL] [Abstract][Full Text] [Related]
17. Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition.
Ortmann J; Amann K; Brandes RP; Kretzler M; Münter K; Parekh N; Traupe T; Lange M; Lattmann T; Barton M
Hypertension; 2004 Dec; 44(6):974-81. PubMed ID: 15545511
[TBL] [Abstract][Full Text] [Related]
18. Podocyte injury and its consequences.
Nagata M
Kidney Int; 2016 Jun; 89(6):1221-30. PubMed ID: 27165817
[TBL] [Abstract][Full Text] [Related]
19. OPN deficiency results in severe glomerulosclerosis in uninephrectomized mice.
Schordan S; Grisk O; Schordan E; Miehe B; Rumpel E; Endlich K; Giebel J; Endlich N
Am J Physiol Renal Physiol; 2013 Jun; 304(12):F1458-70. PubMed ID: 23552865
[TBL] [Abstract][Full Text] [Related]
20. Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS.
Niculovic KM; Blume L; Wedekind H; Kats E; Albers I; Groos S; Abeln M; Schmitz J; Beuke E; Bräsen JH; Melk A; Schiffer M; Weinhold B; Münster-Kühnel AK
J Am Soc Nephrol; 2019 Jun; 30(6):1021-1035. PubMed ID: 31040189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
